PharmAthene, Inc. To Present At Rodman & Renshaw And Aegis Capital Corporation 2014 Investment Conferences
ANNAPOLIS, Md., Sept. 8, 2014 /PRNewswire/ -- PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that Eric I. Richman, President and Chief Executive Officer will present at the following investment conferences.
Event: Rodman & Renshaw 16th Annual Global Investment Conference
Date: Tuesday, September 9, 2014
Place: New York Palace Hotel, New York, NY
Time: 11:40 a.m. EDT; Kennedy II Salon, 4th Floor
Event: Aegis Capital 2014 Healthcare & Technology Conference
Date: Thursday, September 11, 2014
Place: The Encore at Wynn Las Vegas
Time: 10:45 a.m. PDT: Chopin 2
About PharmAthene
PharmAthene is engaged in the development and commercialization of next generation medical countermeasures against biological and chemical threats. PharmAthene's current biodefense portfolio includes the following product candidates:
- SparVax® - a next generation recombinant protective antigen (rPA) anthrax vaccine
- rBChE bioscavenger - a medical countermeasure for nerve agent poisoning by organophosphorous compounds, including nerve gases and pesticides
- Valortim® - a fully human monoclonal antibody for the prevention and treatment of anthrax infection
- Plague vaccine
- Proprietary antimicrobrials directed towards MRSA
For more information about PharmAthene, please visit www.PharmAthene.com.
SOURCE PharmAthene, Inc.